In August 2025, U.S. President Donald Trump imposed a 25% tariff on imports from India, creating significant challenges for industries dependent on India’s affordable manufacturing and sourcing. This policy, aimed at addressing trade imbalances and India’s ties with Russian oil, has highlighted weaknesses in U.S. supply chains, prompting companies to rethink their strategies. Key sectors like textiles, pharmaceuticals, electronics, and logistics are feeling the impact, with U.S. businesses seeking alternatives in Vietnam and Bangladesh for textiles, and Mexico for other products. Pharmaceutical companies are localizing production to counter rising costs, while logistics firms are turning to technology to improve efficiency. The long-term effects on equities and commodities are mixed, with some sectors facing margin pressure while others, like domestic logistics, stand to benefit. Investors are advised to hedge against risks and focus on sectors poised for growth through diversification and technological innovation.